Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2019 June;61(2) > Panminerva Medica 2019 June;61(2):118-27

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

 

REVIEW  HOT TOPICS IN MALE INFERTILITY 

Panminerva Medica 2019 June;61(2):118-27

DOI: 10.23736/S0031-0808.18.03530-9

Copyright © 2018 EDIZIONI MINERVA MEDICA

language: English

Clinical utility of sperm DNA damage in male infertility

Ahmad MAJZOUB 1, 2, Ashok AGARWAL 3 , Sandro C. ESTEVES 4

1 Department of Urology, Hamad Medical Corporation, Doha, Qatar; 2 Department of Urology, Weill Cornell Medicine Qatar, Doha, Qatar; 3 American Center for Reproductive Medicine, Department of Urology, Cleveland Clinic, Cleveland, OH, USA; 4 ANDROFERT Andrology and Human Reproduction Clinic, Referral Center for Male Reproduction, Campinas, Brazil



Sperm DNA fragmentation (SDF) is an advanced test of sperm function that is utilized during male fertility evaluation. Recently, a guideline was published highlighting the detrimental impact of SDF on sperm function identifying practice-based clinical indications for SDF testing. This review illustrates the commonly utilized SDF measurement techniques and explores the current evidence behind their utility in clinical practice. Patients diagnosed with varicocele, unexplained infertility, recurrent pregnancy loss, recurrent failure of assisted reproductive techniques (ART) and those at risk of lifestyle/environmental exposures are recognized candidates for SDF testing. On a therapeutic level, SDF can help in selecting patients for varicocelectomy, choosing the ART modality and intervention associated with highest pregnancy and live birth outcomes and monitoring treatment response in patients with lifestyle risk factors.


KEY WORDS: DNA fragmentation - Varicocele - Male infertility - Assisted reproductive techniques

top of page